Nanobiotix S.A. (NBTX) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nanobiotix Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.158 Good day and welcome to the Nanobiotics Business Update and Full Year 2024 00:00:05.158 -- 00:00:10.725 Financial Results Conference call. At this time, all participants are in a listen-only 00:00:10.725 -- 00:00:16.052 mode. After the speakers' presentations, there will be a question and answer session. 00:00:16.052 -- 00:00:19.316 Please be advised that today's conference is being recorded. 00:00:19.316 -- 00:00:24.342 At this point, I would turn the call over to Greg West, Senior Vice President 00:00:24.342 -- 00:00:27.206 of Investor Relations of Nanobiotics. 00:00:27.206 -- 00:00:29.667 Please go ahead. 00:00:32.195 -- 00:00:33.296 Thank you. 00:00:33.296 -- 00:00:38.282 Good afternoon and good morning, and welcome to the Nanobiotics Conference call to discuss 00:00:38.282 -- 00:00:42.627 our full year 2024 financial and operational results. 00:00:42.627 -- 00:00:47.913 Joining me on the call today are Laurent Levy, co-founder and chief executive officer, 00:00:47.913 -- 00:00:51.937 and Bart Van Ryn, chief financial and business officer. 00:00:51.937 -- 00:00:56.763 As a reminder, today's call is being webcast and will be available on our website for 00:00:56.763 -- 00:00:58.250 replay. 00:00:58.250 -- 00:01:02.874 On the next slide, slide two, I would like to remind you that this call will include 00:01:02.874 -- 00:01:07.939 forward-looking statements, which may include statements regarding the progress, success, 00:01:07.939 -- 00:01:13.144 and timing of our ongoing and planned clinical trials, collaborations, 00:01:13.144 -- 00:01:18.449 regulatory filings, dates of presentation, and future research and development 00:01:18.449 -- 00:01:22.974 efforts, amongst other things. These forward-looking statements are based on cu...